These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8623929)

  • 21. T cell lines specific for a synthetic Heymann nephritis peptide derived from the receptor-associated protein.
    Wu H; Zhang GY; Knight JF
    Clin Exp Immunol; 2000 Jul; 121(1):157-64. PubMed ID: 10886254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of cytoplasmic tail-containing form of gp600/megalin in active Heymann nephritis.
    Oleinikov AV; Makker SP
    J Pathol; 2000 Oct; 192(2):251-6. PubMed ID: 11004703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glomerulopathy induced by a single monoclonal autoantibody against GP330.
    Luca ME; Deelder AM; Hogendoorn PC; Daha MR; Galceran M; van Es LA; de Heer E
    Nephrol Dial Transplant; 1995; 10(4):490-6. PubMed ID: 7623990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor.
    Raychowdhury R; Niles JL; McCluskey RT; Smith JA
    Science; 1989 Jun; 244(4909):1163-5. PubMed ID: 2786251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. gp330 and RAP: the Heymann nephritis antigenic complex.
    Farquhar MG; Kerjaschki D; Lundstrom M; Orlando RA
    Ann N Y Acad Sci; 1994 Sep; 737():96-113. PubMed ID: 7944157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of cDNAs encoding immunogenic regions of gp330, the autoantigen involved in Heymann nephritis.
    Luca ME; De Geus B; Sahali D; Bruijn JA; Verroust P; De Heer E
    Clin Exp Immunol; 1996 May; 104(2):312-7. PubMed ID: 8625526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).
    Kerjaschki D; Neale TJ
    J Am Soc Nephrol; 1996 Dec; 7(12):2518-26. PubMed ID: 8989729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
    van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
    Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis.
    Saito A; Yamazaki H; Rader K; Nakatani A; Ullrich R; Kerjaschki D; Orlando RA; Farquhar MG
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8601-5. PubMed ID: 8710917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a cell line that expresses a cell surface and a soluble form of the gp330/receptor-associated protein (RAP) Heymann nephritis antigenic complex.
    Orlando RA; Farquhar MG
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4082-6. PubMed ID: 8483924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heymann antigen GP330 demonstrates affinity for fibronectin, laminin, and type I collagen and mediates rat proximal tubule epithelial cell adherence to such matrices in vitro.
    Mendrick DL; Chung DC; Rennke HG
    Exp Cell Res; 1990 May; 188(1):23-35. PubMed ID: 1691715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of antigens associated with the apical endocytotic pathway in proximal tubules from rats with heymann nephritis.
    Gutmann EJ; Niles JL; McCluskey RT; Brown D
    Am J Pathol; 1991 May; 138(5):1243-55. PubMed ID: 1708948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
    Natori Y; Hayakawa I; Shibata S
    Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
    Singh AK; Kasinath BS
    Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex.
    Orlando RA; Kerjaschki D; Kurihara H; Biemesderfer D; Farquhar MG
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6698-702. PubMed ID: 1495959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular pathogenesis of experimental membraneous glomerulonephritis (Heymann nephritis)].
    Kerjaschki D
    Pathologe; 1996 Jul; 17(4):262-8. PubMed ID: 8927592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis.
    Specht Grijp-Glandorf RJ; De Heer E; Dekker-Nooren CC; Daha MR; Van Es LA
    Immunology; 1990 Jul; 70(3):290-5. PubMed ID: 1696240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a 400-kd protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritis.
    Kerjaschki D; Horvat R; Binder S; Susani M; Dekan G; Ojha PP; Hillemanns P; Ulrich W; Donini U
    Am J Pathol; 1987 Oct; 129(1):183-91. PubMed ID: 2444109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a pathogenic epitope involved in initiation of Heymann nephritis.
    Kerjaschki D; Ullrich R; Diem K; Pietromonaco S; Orlando RA; Farquhar MG
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11179-83. PubMed ID: 1280820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
    Kerjaschki D; Miettinen A; Farquhar MG
    J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.